
What smart money is saying about Cosmax
1 fund in our archive has pitched Cosmax — most recently Artisan Emerging Markets Fund in September 2026.
Cosmax, Inc. researches, develops, produces, and manufactures cosmetic and health function food products in Korea and internationally. The company operates through Cosmetic Business segment, Custom Cosmetic, and other Business segments. The company offers skincare products under the Capsule+, IS-LCE, CeraPresso, Emulixir, Foamology, IRPT, and Solar Clear brands; base-make up under the Air Cloud, and skin fabric names; and make up under the Xfine, JellTeX, ARTCOTTA, Bi-Coat, creamline, Thixolash, and CRYSTAL PRISM brands; oriental medicine under the Ginsenology name; and fragrance under the Scenteritage brand, as well as hair care products. The company was formerly known as Miroto Korea and changed its name to Cosmax, Inc. in 1994. Cosmax, Inc. was founded in 1992 and is headquartered in Hwaseong-si, South Korea.
Get an email when a fund writes about it
Position history
Every position in Cosmax on record in the archive was reported in Q3 2026, across 1 fund letter, with no move described.
| Quarter | Letters | Bought | Sold | Theses |
|---|---|---|---|---|
| Q3 2026 | 1 | 0 | 0 | 1 |
Fund activity · 1 position
- September 2026
“The main relative contributors in Q3 included WuXi Biologics, Cosmax and MediaTek.”
Cosmax
Fund coverage · 1 thesis
- Artisan Emerging Markets FundSeptember 2026
Cosmax is a cosmetics OEM/ODM leader with strong R&D and manufacturing capabilities, plus exposure to growing global demand for K-beauty.
Read the full thesis
Read every full thesis on Cosmax
Unlock all 1 thesis — the full reasoning behind what funds are buying, plus unlimited access to the entire archive.
View plans→